Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 241-774-1 | CAS number: 17796-82-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin sensitisation
Administrative data
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 008
- Report date:
- 2008
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Remarks:
- Statement of GLP compliance No. G-026
- Type of study:
- mouse local lymph node assay (LLNA)
Test material
- Reference substance name:
- N-(cyclohexylthio)phthalimide
- EC Number:
- 241-774-1
- EC Name:
- N-(cyclohexylthio)phthalimide
- Cas Number:
- 17796-82-6
- Molecular formula:
- C14H15NO2S
- IUPAC Name:
- N-(cyclohexylthio)phthalimide
- Details on test material:
- Duslin, product of Duslo, a.s.
Test batch No.: 041/07
Active substance: 99,42 % weight
Weight loss: 0,08 % weight
Toluene insolubles: 0,05 % weight
Ash: 0,008 % weight
Melting point: first liquid 92,3°C
complete liquid 92,5 °C
Sieve retention: 2,0 mm 0 %
0,5 mm 0 %
Constituent 1
In vivo test system
Test animals
- Species:
- mouse
- Strain:
- CBA
- Sex:
- female
- Details on test animals and environmental conditions:
- The animals (8-12 weeks old, 18-20 g) were housed individually in plastic cages T I (Velaz Praha). The animals (5 pre group) were marked by serial numbers 1-25. These numbers were placed on the cage together with the marking of group.
Housing
The mice were housed according to SOP 002/53204/07 Mice.
Diet
The standard diet MP (TOP DOVO) was served. The supplier of the diet is approved by State Veterinary and Food Administration SR.
Water
Ad libitum.
Environment
Environmental controls for the animal room were set to maintain 22±2°C, a relative humidity of 55 ±10% a minimum of 10 air changes/hour, and a regulated light regime 12/12 (SOP 013/53204/07 Climatic condition in exp. animal house).
Study design: in vivo (non-LLNA)
Inductionopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- other: acetone/olive oil
- Concentration / amount:
- The test substance in concentrations of 5, 1 and 0,5% was applicated in volume of 25 µl to the dorsum of each ear. as positive control α-Hexylcinnamaldehyde in concentration 25%, in the same volume was used. The vehiculum as a control in volume 25 µl was applicated.
Challengeopen allclose all
- Route:
- epicutaneous, open
- Vehicle:
- other: acetone/olive oil
- Concentration / amount:
- The test substance in concentrations of 5, 1 and 0,5% was applicated in volume of 25 µl to the dorsum of each ear. as positive control α-Hexylcinnamaldehyde in concentration 25%, in the same volume was used. The vehiculum as a control in volume 25 µl was applicated.
- No. of animals per dose:
- 15 females - test substance
5 females - control
5 females - positive control - Details on study design:
- Test procedure
Day 1:
Each animal was indetified and the body weight was recorded (SOP G 008/52000/07). To the dorsum of each ear was applicated 25 αl of the appropriate dilution of the test substance, or the vehicle alone.
Days 2 and 3:
The application procedure carried out on day 1 was reeated.
Days 4 and 5:
No treatment.
Day 6:
The body weight of each animal was recorded. 25 µl of phosphate-buffered saline (PBS) containing 20 µCi of 3H-methyl thymidine into all test and control mice via the tail vein was injected.
Five hours later, the animals were killed. The draining auricular lymph nodes from each ear were excised and pooled in PBS for each experimental group (pooled treatment group approach).
Clinical observations
Animals were carefully observed once daily for any clinical signs, either of local irritation at the application site or of systemic toxicity. All observations were systematically recorded with individual records being maintained for each animal.
The clinical observation were scored as o (no effect), + (weak effect), ++ (moderate effect), +++ (strong effect).
Preparation of cell suspensions
Cell suspension of lymph node cell from pooled treatment groups was prepared by gentle mechanical desagregation by glass homogenizer. Lymph node cells were washed with an excess of PBS and centrifuged (SOP 056/211/03) by 600 g at 4°C for 10 min. Suspension of cells were precipitated with 5% trichloroacetic acid (TCA) at 4 °C for 18-20 h. Pellets were centrifuged by 2000 g at 4°C for 5 min., re-suspended in 1 ml TCA and transfered to scintillation vials containing 10 ml of scintillation fluid for 3H-counting.
Determination of cell proliferation (incorporated radioactivity)
Incorporation of 3H-methyl thymidine into the lymph node cells was measured by β-scintillation counting on Liquid scintillation analyzer TRI-CARB, 2000CA, Packard (SOP 023/53202/07) as disintegrations per minute (DPM). The incorporation was expressed as DPM/treatment group.
Calculation of SI and EC3 values
The SI value was obtained by dividing the pooled radioactive incorporation for each treatment group by the incorporation of the pooled vehicle control group.
The concentration eliciting a SI of 3 is identified as the EC3 value and is calculated by linear interpolation of points on the dose-response curve, immediately above and below threefold the threshold having the coordinates (a,b) and (c,d) according to the equation : EC3 = c+[(3-d)/(b-d)]x(a-c). - Challenge controls:
- 5 females - control
5 females - positive control - Positive control substance(s):
- yes
- Remarks:
- α-Hexylcinnamaldehyde
Study design: in vivo (LLNA)
- Vehicle:
- acetone/olive oil (4:1 v/v)
- Concentration:
- 0,5%, 1% and 5% Duslin
- No. of animals per dose:
- 5 females
- Positive control substance(s):
- hexyl cinnamic aldehyde (CAS No 101-86-0)
Results and discussion
- Positive control results:
- Clinical observations
Animals were carefully observed for any clinical signs, either of local irritation at the application site or of systemic toxicity.
The daily clinical observation of the animals did not show any visible clinical symptoms.
Body Weights
The animal body weights were measured at the start of the test and at the scheduled kill. In course of the experiment the increase of mean body weight was observed in group treated at concentration 5% (from 24,04 to 24,49 g) and slight decrease were observed in animal groups which were treated at concentrations 1 and 0,5% of tested substance (difference between initial mean body weight and terminal body weight was 0,04 and 0,28 g resp.) This suggested, that the test substance slightly affected the food intake of animals only at lowest used concentration. The individual and mean values of animal body weights of the control group, positive control group and three test substance groups are shown in tab.1
Lymph node proliferation
After application of Duslin the dose dependent increase of the lymph node weights was registered. The pooled lymph node weights of treated groups were 0,0394 g for 0,5% concentration, 0,042 g for 1% concentration and 0,0855 g for 5% concentration of tested substance. The lymph node weight of control group was 0,0288 g and for positive control group was 0,0388 g. The DPM values for treated groups were 923.1, 1166,3 and 3858,9. The positive responsens, with SI value 3,27 and 10,83 resp. were registered after application of test substance at concentration 1 and 5 % resp. The calculated EC3 value was 0,8 %. The lymph node weight, SI values and EC3 value are shown in table 2.
In vivo (LLNA)
Resultsopen allclose all
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: Reading: 1st reading. . Hours after challenge: 5.0. Group: positive control.
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 5.0. Group: test group. Dose level: 1,0%, Duslin. No with. + reactions: 5.0. Total no. in groups: 5.0. Clinical observations: The daily clinical observation of the animals did not show any visible clinical symptoms.
- Parameter:
- other: Migrated information from in vivo LLNA study
- Remarks on result:
- other: see Remark
- Remarks:
- Reading: 1st reading. . Hours after challenge: 5.0. Group: test group. Dose level: 5% Duslin. No with. + reactions: 5.0. Total no. in groups: 5.0. Clinical observations: The daily clinical observation of the animals did not show any visible clinical symptoms..
- Parameter:
- SI
- Remarks on result:
- other: see Remark
- Remarks:
- SI EC3 Control: - - Pos. Control: 3,15 - Duslin 5%: 10,83 0,80 Duslin 1%: 3,27 - Duslin 0,5%: 2,59 -
- Parameter:
- other: disintegrations per minute (DPM)
- Remarks on result:
- other: Control: 356,2 Pos. Control: 1122,4 Duslin 5%: 3858,9 Duslin 1%: 1166,3 Duslin 0,5%: 923,1
Applicant's summary and conclusion
- Interpretation of results:
- sensitising
- Remarks:
- Migrated information sensitising potency, moderate allergen
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.